ARTICLE | Clinical News
rNAPc2: Development halted
August 6, 2007 7:00 AM UTC
NUVO will discontinue an ongoing Phase II trial in colorectal cancer and suspend development of rNAPc2 for all indications, which include cancer and acute coronary syndrome. The company said it made t...